Home › Metabolic Disorders › Washington
Metabolic Disorders clinical trials in Washington
4 studies for Metabolic Disorders are looking for participants at sites in Washington.
Cities in Washington
METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
RecruitingPhase 2
Ages 18 to 69 · All sexes · Updated Sep 15, 2026 · NCT07699380A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Bellevue
- 89bio Clinical Study Site, Seattle
- 89bio Clinical Study Site, Seattle
- and 1 more
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Sep 3, 2026 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Bellevue
- 89bio Clinical Study Site, Seattle
- 89bio Clinical Study Site, Seattle
- and 1 more
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 3, 2026 · NCT06419374Rare and Atypical Diabetes Network
- University of Washington, Seattle
RecruitingObservational study
All ages · All sexes · Updated Aug 14, 2025 · NCT05544266From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.